Results for tag: "Nucleic Acid Therapeutics CDMO"

The Nucleic Acid Therapeutics CDMO market is a subset of the Pharmaceutical Manufacturing industry. It focuses on the production of nucleic acid-based drugs, such as DNA and RNA-based therapeutics, for use in the treatment of various diseases. These drugs are produced using a variety of techniques, including gene therapy, gene editing, and gene silencing. The market is driven by the increasing demand for personalized medicines, as well as the need for more efficient and cost-effective production methods. The Nucleic Acid Therapeutics CDMO market is highly competitive, with a number of companies offering services in the field. These include companies such as Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, and Moderna Therapeutics. Other companies in the market include Cellectis, CRISPR Therapeutics, and Intellia Therapeutics. Show Less Read more